Donor-Derived Infections: Approach and Management
After participating in this webinar, the attendee will be able to:
- Describe the epidemiology of donor derived infections (consider 10-year DTAC review and other DTAC studies).
- Outline the factors to consider during the evaluation of a deceased donor with suspected or proven infection.
- Understand changes to PHS risk definitions and recommendations.
- Describe the emerging novel deceased donor populations (SARS-CoV-2 NAT+, HBsAg+ & HBV DNA+, and Monkeypox).
- Cameron Wolfe, MD, MBBS(Hons), MPH, FIDSA, FAST • Associate Professor of Medicine, Infectious Disease, Duke University Medical Center, Durham, NC
- Marian Michaels, MD, MPH, FAST • Professor of Pediatrics and Surgery, Division of Pediatric Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA
- Ricardo La Hoz, MD, FACP, FIDSA, FAST • Associate Professor of Medicine, Division of Infectious Diseases, University of Texas Southwestern Medical Center, Dallas, TX
The AST Education Committee would like to thank the Infectious Disease Community of Practice (IDCOP) for suggesting this topic as part of the 2022-2023 T3 webinar series. Learn more about AST's COPs at www.myast.org/cops.
Educational Content Disclaimer: The content, information, opinions, and viewpoints contained in educational materials housed on and linked from the AST web site are those of the authors or contributors of such materials. While the AST and its committees take great care to screen the credentials of the contributors and make every attempt to review the contents, AST MAKES NO WARRANTY, EXPRESSED OR IMPLIED, as to the completeness or accuracy of the content contained in the educational materials or on this website. The reader of these materials uses these materials at his or her own risk, and AST shall not be responsible for any errors, omissions, or inaccuracies in these materials, whether arising through negligence, oversight, or otherwise. Reliance on any information appearing on this site is strictly at your own risk. Read the full disclaimer.